2004 - Abstracts From Professional Poster
Presentations at AMCP’s 2004 Educational Conference
October, 2004
There are at least 3 posters in here about Memantine
(mostly about Mild to Moderate usage)
MEMANTINE IS SAFE FOR SHORT- AND LONG-TERM
TREATMENT OF DEMENTIA
Graham SM*, Jonas JM, Lee GS, Goetz MA, Stöffler A, Schraa C,
Wirth Y. Forest Research Institute, Harborside Financial Center,
Plaza V, 19th Fl., Jersey City, NJ 07311
MEMANTINE MONOTHERAPY INCREASES BRAIN
METABOLISM AND EFFECTIVELY TREATS MILD-TO-MODERATE
ALZHEIMER’S DISEASE
Potkin SG*, Alva G, McDonald S, Gergel I, Keator DB, Fallon JH.
University of California, Irvine, Dept. of Psychiatry, 101 The City
Drive, Irvine, CA 92668
OBJECTIVE: Memantine is a low-moderate affinity, uncompetitive
MEMANTINE TREATMENT FOR MILD-TO-SEVERE
ALZHEIMER’S DISEASE: CLINICAL TRIALS SUMMARY
Tariot PN, Farlow MR, Doody R, Peskind ER*, Winblad B, Stöffler A,
Graham SM, McDonald S. University of Washington, Dept. of
Psychiatry, 1959 N.E. Pacific, Seattle, WA 98195
amcp.org |
